GIPR Gene Polymorphism and Weight Gain in Patients With Schizophrenia Treated With Olanzapine
- PMID: 25321336
- DOI: 10.1176/appi.neuropsych.13120389
GIPR Gene Polymorphism and Weight Gain in Patients With Schizophrenia Treated With Olanzapine
Abstract
Association between gastric inhibitory polypeptide receptor polymorphism, rs10423928, and body mass index in olanzapine-treated schizophrenia was examined. Body mass index change for the A/T+A/A genotypes was significantly higher than that for the T/T genotype. rs10423928 may predict weight gain in schizophrenia.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
